The CDP-choline pathway, which is the sole pathway for de novo synthesis of PC in non-hepatic cells, may not be sufficient for PC supply in cancer cells; therefore, cancer cells activate the PEMT pathway to cover the increased demand for PC to maintain an adequate PC/PE ratio, membrane integrity and cell survival. This evidence concerns the gene PEMT and cancer.